Literature DB >> 28063109

Mutation screening of ACKR3 and COPS8 in kidney cancer cases from the CONFIRM study.

Maryam Mahmoodi1, Tu Nguyen-Dumont2, Fleur Hammet1, Bernard J Pope3,4, Daniel J Park1,3, Melissa C Southey1, John M Darlow5,6, Fiona Bruinsma7, Ingrid Winship8,9.   

Abstract

An apparently balanced t(2;3)(q37.3;q13.2) translocation that appears to segregate with renal cell carcinoma (RCC) has indicated potential areas to search for the elusive genetic basis of clear cell RCC. We applied Hi-Plex targeted sequencing to analyse germline DNA from 479 individuals affected with clear cell RCC for this breakpoint translocation and genetic variants in neighbouring genes on chromosome 2, ACKR3 and COPS8. While only synonymous variants were found in COPS8, one of the missense variants in ACKR3:c.892C>T, observed in 4/479 individuals screened (0.8%), was predicted likely to damage ACKR3 function. Identification of causal genes for RCC has potential clinical utility, where risk assessment and risk management can offer better outcomes, with surveillance for at-risk relatives and nephron sparing surgery through earlier intervention.

Entities:  

Keywords:  ACKR3; COPS8; Hi-Plex; Kidney cancer; Massively parallel sequencing; Mutation screening

Mesh:

Substances:

Year:  2017        PMID: 28063109     DOI: 10.1007/s10689-016-9961-x

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  24 in total

1.  Case report: renal cell carcinoma segregating with a t(2;3)(q37.3;q13.2) chromosomal translocation in an Ashkenazi Jewish family.

Authors:  L McKay; M Frydenberg; L Lipton; F Norris; I Winship
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

2.  A high-plex PCR approach for massively parallel sequencing.

Authors:  Tú Nguyen-Dumont; Bernard J Pope; Fleur Hammet; Melissa C Southey; Daniel J Park
Journal:  Biotechniques       Date:  2013-08       Impact factor: 1.993

3.  Abridged adapter primers increase the target scope of Hi-Plex.

Authors:  Tú Nguyen-Dumont; Fleur Hammet; Maryam Mahmoodi; Bernard J Pope; Graham G Giles; John L Hopper; Melissa C Southey; Daniel J Park
Journal:  Biotechniques       Date:  2015-01-01       Impact factor: 1.993

Review 4.  Hereditary renal cancer syndromes: an update of a systematic review.

Authors:  Jérôme Verine; Amélie Pluvinage; Guilhem Bousquet; Jacqueline Lehmann-Che; Cédric de Bazelaire; Nadem Soufir; Pierre Mongiat-Artus
Journal:  Eur Urol       Date:  2010-08-27       Impact factor: 20.096

5.  Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer.

Authors:  Ian P M Tomlinson; N Afrina Alam; Andrew J Rowan; Ella Barclay; Emma E M Jaeger; David Kelsell; Irene Leigh; Patricia Gorman; Hanan Lamlum; Shamima Rahman; Rebecca R Roylance; Simon Olpin; Stephen Bevan; Karen Barker; Nicholas Hearle; Richard S Houlston; Maija Kiuru; Rainer Lehtonen; Auli Karhu; Susa Vilkki; Päivi Laiho; Carita Eklund; Outi Vierimaa; Kristiina Aittomäki; Marja Hietala; Pertti Sistonen; Anders Paetau; Reijo Salovaara; Riitta Herva; Virpi Launonen; Lauri A Aaltonen
Journal:  Nat Genet       Date:  2002-02-25       Impact factor: 38.330

6.  Birt-Hogg-Dubé syndrome: a novel marker of kidney neoplasia.

Authors:  J R Toro; G Glenn; P Duray; T Darling; G Weirich; B Zbar; M Linehan; M L Turner
Journal:  Arch Dermatol       Date:  1999-10

7.  Predicting functional effect of human missense mutations using PolyPhen-2.

Authors:  Ivan Adzhubei; Daniel M Jordan; Shamil R Sunyaev
Journal:  Curr Protoc Hum Genet       Date:  2013-01

Review 8.  von Hippel-Lindau disease.

Authors:  Russell R Lonser; Gladys M Glenn; McClellan Walther; Emily Y Chew; Steven K Libutti; W Marston Linehan; Edward H Oldfield
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

9.  A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development.

Authors:  Jennifer M Burns; Bretton C Summers; Yu Wang; Anita Melikian; Rob Berahovich; Zhenhua Miao; Mark E T Penfold; Mary Jean Sunshine; Dan R Littman; Calvin J Kuo; Kevin Wei; Brian E McMaster; Kim Wright; Maureen C Howard; Thomas J Schall
Journal:  J Exp Med       Date:  2006-08-28       Impact factor: 14.307

10.  UNDR ROVER - a fast and accurate variant caller for targeted DNA sequencing.

Authors:  Daniel J Park; Roger Li; Edmund Lau; Peter Georgeson; Tú Nguyen-Dumont; Bernard J Pope
Journal:  BMC Bioinformatics       Date:  2016-04-16       Impact factor: 3.169

View more
  3 in total

1.  Characterization of the Prognostic Values of the CXCR1-7 in Clear Cell Renal Cell Carcinoma (ccRCC) Microenvironment.

Authors:  Zhulin Wu; Yingzhao Zhang; Xiang Chen; Wanjun Tan; Li He; Lisheng Peng
Journal:  Front Mol Biosci       Date:  2020-11-25

2.  A new risk score based on twelve hepatocellular carcinoma-specific gene expression can predict the patients' prognosis.

Authors:  Ting Lin; Jingxian Gu; Kai Qu; Xing Zhang; Xiaohua Ma; Runchen Miao; Xiaohong Xiang; Yunong Fu; Wenquan Niu; Junjun She; Chang Liu
Journal:  Aging (Albany NY)       Date:  2018-09-21       Impact factor: 5.682

3.  Expression profile-based screening for critical genes reveals S100A4, ACKR3 and CDH1 in docetaxel-resistant prostate cancer cells.

Authors:  Sha Zhu; Zhixue Min; Xianli Qiao; Shengxian Chen; Jian Yang; Xiao Zhang; Xigang Liu; Weijie Ran; Renguang Lv; Ying Lin; Jin Wang
Journal:  Aging (Albany NY)       Date:  2019-12-29       Impact factor: 5.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.